Low-Grade Fumarate Hydratase-Deficient Renal Cell Carcinoma in a 30-Year-Old Female

Int J Surg Pathol. 2022 Apr;30(2):184-189. doi: 10.1177/10668969211026241. Epub 2021 Jun 28.

Abstract

Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare and clinically aggressive RCC subtype that is commonly associated with the hereditary leiomyomatosis and renal cell carcinoma syndrome. The diagnostic hallmark of FH-deficient RCC is a high-grade microscopic appearance with prominent inclusion-like eosinophilic nucleoli and perinucleolar halos. Herein we report a case of an FH-deficient RCC in a 30-year-old female that exhibited low-grade nuclei and abundant eosinophilic cytoplasm, reminiscent of the clinically more indolent succinate dehydrogenase-deficient RCC subtype and the newly described eintity, eosinophilic, solid and cystic RCC. This case illustrates that FH-deficient RCC can have a wide spectrum of microscopic appearances, including low-grade eosinophilic RCC. In addition, it highlights that a low threshold to perform the immunohistochemical stains for FH and S-(2-succino) cysteine is warranted in RCC cases with unusual and even low-grade eosinophilic morphology.

Keywords: FH; HLRCC; SDH; fumarate; immunohistochemistry; renal cell carcinoma; succinate.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma, Renal Cell* / diagnosis
  • Carcinoma, Renal Cell* / pathology
  • Cell Nucleus / pathology
  • Female
  • Fumarate Hydratase / genetics
  • Humans
  • Kidney Neoplasms* / diagnosis
  • Kidney Neoplasms* / pathology
  • Leiomyomatosis* / diagnosis
  • Leiomyomatosis* / pathology
  • Skin Neoplasms* / diagnosis
  • Uterine Neoplasms* / diagnosis
  • Uterine Neoplasms* / pathology

Substances

  • Fumarate Hydratase